Navigation Links
Biopure Granted Additional 180 Day Compliance Period by NASDAQ

CAMBRIDGE, Mass., June 12 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that The NASDAQ Stock Market has granted the Company an additional 180 days, or until December 8, 2008, to regain compliance with Marketplace Rule 4310(c)(4) requiring a minimum bid price of $1.00 for continued listing. Currently, the Company meets all other required inclusion criteria for the NASDAQ Capital Market. If, at any time before December 8, 2008, the bid price of the Company's common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Company will be provided written notification that it complies with the Marketplace Rule.

If compliance with the Marketplace Rule cannot be demonstrated by December 8, 2008, NASDAQ will issue a delisting notice to the Company.

Biopure Corporation

Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) [hemoglobin glutamer - 250 (bovine)], or HBOC-201, is approved for sale in South Africa for the treatment of surgical patients who are acutely anemic. The company is developing Hemopure for other indications and is supporting the U.S. Navy's government-funded efforts to develop a potential out-of-hospital trauma indication. Biopure's veterinary product Oxyglobin(R) [hemoglobin glutamer - 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs. Biopure has sold approximately 200,000 units of Oxyglobin since its launch.

Tiana Gorham

Biopure Corporation

(617) 234-6826

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biopure Announces MHRA Meeting Update
2. Biopure Announces 2008 Second Quarter Financial Results
3. Biopure Appoints Dechra Exclusive U.S. Distributor of Oxyglobin
4. Biopure Announces Date to Meet with UKs Medicines and Healthcare Products Agency
5. Biopure Operations Compliant With U.K. Manufacturing Guidelines
6. Biopure Appoints New Independent Auditor
7. Biopure Completes U.K. Regulatory Agency Inspection
8. Biopure Announces 2008 First Quarter Financial Results
9. Biopure Launches Updated Website
10. Biopure Announces Pricing of Equity Offering
11. Biopure Gives Update on Malaysia Joint Venture Discussions
Post Your Comments:
(Date:12/1/2015)... ... 01, 2015 , ... The American Society of Gynecologic Laparoscopists, ... Mathews will join fellow surgeons in the shared pursuit of ÔÇťadvancing minimally ... urogynecologist, founder of Plano Urogynecology Associates and Fellow of the American College ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Manufacturing Practice (GMP) 10000 in the Santiago Marriott. The Global Stem Cells Group ... by a world-class team of qualified medical researchers and practitioners, experienced in administering ...
(Date:11/30/2015)... , Nov. 30, 2015  Culprits beware, a ... chemistry professor Jan Halámek, is taking crime scene ...   -->   ... --> --> ... have discovered a straightforward concept for identifying whether ...
(Date:11/30/2015)... , Nov. 30, 2015  Champions Oncology, Inc. ... and services to personalize the development and use of ... Chief Executive Officer, will be presenting at the LD ... 4:30pm Pacific Standard Time (PST).  The conference, held at ... Los Angeles, CA , will feature 200 small/micro-cap ...
Breaking Biology Technology:
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
Breaking Biology News(10 mins):